The development of new radiopharmaceuticals
- 1 January 1990
- journal article
- review article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 16 (4-6) , 373-385
- https://doi.org/10.1007/bf00842796
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Is 99Tcm hexamethyl-propyleneamine oxime uptake in the tissues related to glutathione cellular content?Nuclear Medicine Communications, 1989
- 99Tcm sestamibi — a new agent for parathyroid imagingNuclear Medicine Communications, 1989
- Intracellular localization of 99Tcm-d, 1-HMPAO and 201T1-DDC in rat brainNuclear Medicine Communications, 1989
- 99Tcm-labelled anti-CEA monoclonal antibody for tumour immunoscintigraphyNuclear Medicine Communications, 1989
- A rapid method for the preparation of 99Tcm hexametazime-labelled leucocytesNuclear Medicine Communications, 1988
- DIAGNOSTIC RADIONUCLIDE IMAGING OF AMYLOID: BIOLOGICAL TARGETING BY CIRCULATING HUMAN SERUM AMYLOID P COMPONENTThe Lancet, 1988
- Strontium-89 radionuclide therapy: a dosimetric study using impulse response function analysisThe British Journal of Radiology, 1987
- Neuroblastoma imaged with123I meta-iodo-benzylguanidine and with123I-labelled monoclonal antibody, UJ13A, against neural tissueThe British Journal of Radiology, 1985
- Ovarian cancerNuclear Medicine Communications, 1984
- Whole-body distribution of radioactivity after intraperitoneal administration of32P colloidsThe British Journal of Radiology, 1984